| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |